Na Lei

Dr. Na Lei


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2025 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
LZLianna Zhao
Lianna Zhao
RYRun Yin
Run Yin
KZKailing Zhang
Kailing Zhang
JHJinqing Huang
Jinqing Huang
RZRuiyu Zheng
Ruiyu Zheng
YXYuhuan Xie
Yuhuan Xie
Depression is a severe mental disorder with evidence suggesting that microglial modulation can play a crucial role in elevating brain-derived neurotrophic factor (BDNF) level in hippocampus. Previous studies highlight that Cang-ai volatile oil (CAVO) exhibits antidepressant effects by inhibiting microglial activation and neuroinflammation while upregulating BDNF expression. This study aimed to investigate CAVO's antidepressant effects through modulating microglial phenotypic polarization and the BDNF/cAMP response element binding protein (CREB) pathway. Results showed that in a Lipopolysaccharide (LPS)-induced depression model, CAVO increased the animals' body weight (BW) and alleviated depressive-like behaviors. CAVO reduced the number of Iba1 and CD16/32 co-localized cells and decreased pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), while increasing IL-4, IL-10, and BDNF levels. In LPS-activated BV2 cells, CAVO reversed the elevated release of pro-inflammatory cytokines and enhanced anti-inflammatory factors, demonstrating a dose-dependent response. Additionally, CAVO treatment significantly elevated CD163 expression while reducing CD86 expression, with the most prominent effects observed at the higher CAVO dose, indicating the potential of CAVO to modulate microglial polarization from an M1 pro-inflammatory state towards an M2 anti-inflammatory phenotype. Western blot analysis confirmed that CAVO elevated BDNF, AKT, and p-CREB while reducing ERK1/2 expression in both mouse and BV2 cells. The findings support the therapeutic potential of CAVO in depression treatment through modulation of inflammatory responses and enhancement of BDNF synthesis via the BDNF/CREB pathway in microglia.

11 March 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Open access
MLMinghong Li
Minghong Li
ZTZilei Tang
Zilei Tang
LYLiuyan Yu
Liuyan Yu
YLYingming Li
Yingming Li
WMWenyu Ma
Wenyu Ma
YXYuhuan Xie
Yuhuan Xie
Acute alcohol intoxication is one of the leading causes of coma. A well-regarded Chinese herbal formula, known as An-Gong-Niu-Huang-Wan (AGNHW), has garnered recognition for its efficacy in treating various brain disorders associated with impaired consciousness, including acute alcohol-induced coma. Despite its clinical effectiveness, the scientific community lacks comprehensive research on the mechanistic aspects of AGNHW's impact on the electroencephalogram (EEG) patterns observed during alcohol-induced coma. Gaining a deeper understanding of AGNHW's mechanism of action in relation to EEG characteristics would hold immense importance, serving as a solid foundation for further advancing its clinical therapeutic application. The study sought to investigate the impact of AGNHW on EEG activity and sleep EEG patterns in rats with alcoholic-induced coma. A rat model of alcohol-induced coma was used to examine the effects of AGNHW on EEG patterns. Male Sprague-Dawley rats were intraperitoneally injected with 32% ethanol to induce a coma, followed by treatment with AGNHW. Wireless electrodes were implanted in the cortex of the rats to obtain EEG signals. Our analysis focused on evaluating alterations in the Rat Coma Scale (RCS), as well as assessing changes in the frequency and distribution of EEG patterns, sleep rhythms, and body temperature subsequent to AGNHW treatment. The study found a significant increase in the δ-band power ratio, as well as a decrease in RCS scores and β-band power ratio after modeling. AGNHW treatment significantly reduced the δ-band power ratio and increased the β-band power ratio compared to naloxone, suggesting its superior arousal effects. The results also revealed a decrease in the time proportion of WAKE and REM EEG patterns after modeling, accompanied by a significant increase in the time proportion of NREM EEG patterns. Both naloxone and AGNHW effectively counteracted the disordered sleep EEG patterns. Additionally, AGNHW was more effective than naloxone in improving hypothermia caused by acute alcohol poisoning in rats. Our study provides evidence for the arousal effects of AGNHW in alcohol-induced coma rats. It also suggests a potential role for AGNHW in regulating post-comatose sleep rhythm disorders.

1 February 2020
Verified
Journal Article
Closed access
YYYuannan Xu Yuannan
Yuannan Xu Yuannan
PPPeixin Guo Peixin
Peixin Guo Peixin
YYYulian Wang Yulian
Yulian Wang Yulian
TTTingting Xia Tingting
Tingting Xia Tingting
YYYue Shen Yue
Yue Shen Yue
YXYuhuan Xie
Yuhuan Xie

Verified
Journal Article
Open access
PDF file
YLYingdi Liao
Yingdi Liao
LZLianna Zhao
Lianna Zhao
YZYouyang Zhu
Youyang Zhu
SYSirong Ye
Sirong Ye
JHJinqing Huang
Jinqing Huang
YXYuhuan Xie
Yuhuan Xie
Traumatic brain injury (TBI), a major cause of persistent cognitive impairment (CI), increases the long-term risk of developing dementia, including Alzheimer’s disease (AD). To elucidate this association, we systematically reviewed fluid biomarkers linked to post-TBI cognitive outcomes. A comprehensive search of the PubMed, Embase, and Cochrane Library databases was performed. A total of 29 clinical studies were included, reporting on several biomarkers related to neural injury and repair, AD-like pathology, and inflammation. Among these, neurofilament light chain (NfL), ubiquitin C-terminal hydrolase L1, total tau, and glial fibrillary acidic protein (GFAP) were consistently associated with CI and brain atrophy across various TBI severities and stages. Notably, certain biomarkers assessed during the acute phase (within 7 days post-injury), such as brain-derived neurotrophic factor, neuron-specific enolase, and interleukin-1β, showed significant correlations with CI. In contrast, elevated levels of GFAP and NfL measured during the recovery phase (6 months to 8 years post-injury) were significantly associated with TBI-related CI (TBI-CI). The findings also highlighted that axonal injury, glial activation, neuroinflammation, neuronal damage, and degeneration drive TBI-CI, with tau pathology and synaptic dysfunction emerging as potential bridges from TBI to AD. This review underscores the critical temporal dynamics of fluid biomarkers in TBI-CI, revealing that stage-specific biomarker profiles mirror distinct underlying pathophysiological processes. Future longitudinal studies should focus on well-characterized patient subgroups, adopt standardized diagnostic criteria, and integrate fluid biomarkers with neuroimaging and genetic data.